Diffusion and Perfusion MR Imaging of Acute Ischemic Stroke

Magnetic Resonance Imaging Clinics of North America

Volumn 17, Issue 2, 2009, Pages 291-313

  Harris, Ashley D ^a,b,c   Coutts, Shelagh B ^a,b,c   Frayne, Richard ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

Diffusion; Diffusion perfusion mismatch; Hyperacute ischemic stroke; Infarction; Ischemia; Perfusion; Thrombolysis; Transient ischemic attack

Indexed keywords

PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; GRAY MATTER; HUMAN; PATHOPHYSIOLOGY; PERFUSION WEIGHTED IMAGING; QUANTITATIVE ANALYSIS; REVIEW; WHITE MATTER;

BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; PERFUSION IMAGING; STROKE;

EID: 65349122977     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2009.02.001     Document Type: Review

References (88)

1. Doyle K.P., Simon R.P., and Stenzel-Poore M.P. Mechanisms of ischemic brain damage. Neuropharmacology 55 3 (2008) 310-318
2. Davis S.M., Donnan G.A., Butcher K.S., et al. Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging. Curr Opin Neurol 18 1 (2005) 47-52
3. Baron J.C. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 11 Suppl 1 (2001) 2-8
4. Perthen J.E., Calamante F., Gadian D.G., et al. Is quantification of bolus tracking MRI reliable without deconvolution?. Magn Reson Med 47 1 (2002) 61-67
5. Lin W., Lee J.M., Lee Y.Z., et al. Temporal relationship between apparent diffusion coefficient and absolute measurements of cerebral blood flow in acute stroke patients. Stroke 34 1 (2003) 64-70
6. Haley Jr. E.C., Brott T.G., Sheppard G.L., et al. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group. Stroke 24 7 (1993) 1000-1004
7. Heiss W.D., Thiel A., Grond M., et al. Which targets are relevant for therapy of acute ischemic stroke?. Stroke 30 7 (1999) 1486-1489
8. Schellinger P.D., Fiebach J.B., and Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 34 2 (2003) 575-583
9. Umemura A., Suzuka T., and Yamada K. Quantitative measurement of cerebral blood flow by (99m)Tc-HMPAO SPECT in acute ischaemic stroke: usefulness in determining therapeutic options. J Neurol Neurosurg Psychiatry 69 4 (2000) 472-478
10. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333 24 (1995) 1581-1587
11. Olivot JM, Mlynash M, Thijs VN, Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE) 2008;39(8):2258-63
12. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 282 21 (1999) 2003-2011
13. Dijkhuizen R.M., Asahi M., Wu O., et al. Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging. J Cereb Blood Flow Metab 21 8 (2001) 964-971
14. Dijkhuizen R.M., Asahi M., Wu O., et al. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model. Stroke 33 8 (2002) 2100-2104
15. Heidenreich J.O., Hsu D., Wang G., et al. Magnetic resonance imaging results can affect therapy decisions in hyperacute stroke care. Acta Radiol 49 5 (2008) 550-557
16. Albers G.W., Thijs V.N., Wechsler L., et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 60 5 (2006) 508-517
17. Davis S.M., Donnan G.A., Parsons M.W., et al. Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 7 4 (2008) 299-309
18. Schellinger P.D. EPITHET: failed chance or new hope?. Lancet Neurol 7 4 (2008) 286-287
19. Schellinger P.D., Jansen O., Fiebach J.B., et al. Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. AJNR Am J Neuroradiol 21 7 (2000) 1184-1189
20. Baron J.C., von Kummer R., and del Zoppo G.J. Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. Stroke 26 12 (1995) 2219-2221
21. Gonzalez R.G. Imaging-guided acute ischemic stroke therapy: from "time is brain" to "physiology is brain.". AJNR Am J Neuroradiol 27 4 (2006) 728-735
22. Kakuda W., Lansberg M.G., Thijs V.N., et al. Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab 28 5 (2008) 887-891
23. Cercignani M., and Horsfield M.A. The physical basis of diffusion-weighted MRI. J Neurol Sci 186 Suppl 1 (2001) S11-s14
24. Stejskal E., and Tanner J. Spin diffusion measurements: spin-echoes in the presence of a time-dependent field gradient. J Chem Phys 42 1 (1965) 288-292
25. Moseley M.E., Kucharczyk J., Mintorovitch J., et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol 11 3 (1990) 423-429
26. Moseley M.E., Mintorovitch J., Cohen Y., et al. Early detection of ischemic injury: comparison of spectroscopy, diffusion-, T2-, and magnetic susceptibility-weighted MRI in cats. Acta Neurochir Suppl (Wien) 51 (1990) 207-209
27. +,K(+)-ATPase activity. J Cereb Blood Flow Metab 14 2 (1994) 332-336
28. Sevick R.J., Kucharczyk J., Mintorovitch J., et al. Diffusion-weighted MR imaging and T2-weighted MR imaging in acute cerebral ischaemia: comparison and correlation with histopathology. Acta Neurochir Suppl (Wien) 51 (1990) 210-212
29. Sevick R.J., Kanda F., Mintorovitch J., et al. Cytotoxic brain edema: assessment with diffusion-weighted MR imaging. Radiology 185 3 (1992) 687-690
30. Gass A., Niendorf T., and Hirsch J.G. Acute and chronic changes of the apparent diffusion coefficient in neurological disorders-biophysical mechanisms and possible underlying histopathology. J Neurol Sci 186 Suppl 1 (2001) S15-23
31. Kidwell C.S., Saver J.L., Mattiello J., et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 47 4 (2000) 462-469
32. Pereira R.S., Harris A.D., Sevick R.J., et al. Effect of b value on contrast during diffusion-weighted magnetic resonance imaging assessment of acute ischemic stroke. J Magn Reson Imaging 15 5 (2002) 591-596
33. Chen P.E., Simon J.E., Hill M.D., et al. Acute ischemic stroke: accuracy of diffusion-weighted MR imaging-effects of b value and cerebrospinal fluid suppression. Radiology 238 1 (2006) 232-239
34. Falconer J.C., and Narayana P.A. Cerebrospinal fluid-suppressed high-resolution diffusion imaging of human brain. Magn Reson Med 37 1 (1997) 119-123
35. Latour L.L., and Warach S. Cerebral spinal fluid contamination of the measurement of the apparent diffusion coefficient of water in acute stroke. Magn Reson Med 48 3 (2002) 478-486
36. Simon J.E., Czechowsky D.K., Hill M.D., et al. Fluid-attenuated inversion recovery preparation: not an improvement over conventional diffusion-weighted imaging at 3T in acute ischemic stroke. AJNR Am J Neuroradiol 25 10 (2004) 1653-1658
37. Bykowski J.L., Latour L.L., and Warach S. More accurate identification of reversible ischemic injury in human stroke by cerebrospinal fluid suppressed diffusion-weighted imaging. Stroke 35 5 (2004) 1100-1106
38. Kane I., Carpenter T., Chappell F., et al. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke 38 12 (2007) 3158-3164
39. Carroll T.J., Teneggi V., Jobin M., et al. Absolute quantification of cerebral blood flow with magnetic resonance, reproducibility of the method, and comparison with H2(15)O positron emission tomography. J Cereb Blood Flow Metab 22 9 (2002) 1149-1156
40. Ostergaard L., Weisskoff R.M., Chesler D.A., et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 36 5 (1996) 715-725
41. Chen J.J., Smith M.R., and Frayne R. The impact of partial-volume effects in dynamic susceptibility contrast magnetic resonance perfusion imaging. J Magn Reson Imaging 22 3 (2005) 390-399
42. Calamante F., Gadian D.G., and Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 44 3 (2000) 466-473
43. Salluzzi M., Frayne R., and Smith M.R. Is correction necessary when clinically determining quantitative cerebral perfusion parameters from multi-slice dynamic susceptibility contrast MR studies?. Phys Med Biol 51 2 (2006) 407-424
44. Smith M.R., Lu H., Trochet S., et al. Removing the effect of SVD algorithmic artifacts present in quantitative MR perfusion studies. Magn Reson Med 51 3 (2004) 631-634
45. Schellinger P.D., Thomalla G., Fiehler J., et al. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke 38 10 (2007) 2640-2645
46. Lansberg M.G., Thijs V.N., Bammer R., et al. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke 38 8 (2007) 2275-2278
47. Singer O.C., Humpich M.C., Fiehler J., et al. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol 63 1 (2008) 52-60
48. Bristow M.S., Simon J.E., Brown R.A., et al. MR perfusion and diffusion in acute ischemic stroke: human gray and white matter have different thresholds for infarction. J Cereb Blood Flow Metab 25 10 (2005) 1280-1287
49. Lansberg M.G., Thijs V.N., Hamilton S., et al. Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE. Stroke 38 6 (2007) 1826-1830
50. Rowley H.A. Extending the time window for thrombolysis: evidence from acute stroke trials. Neuroimaging Clin N Am 15 3 (2005) 575-587 x
51. Parsons M.W., Barber P.A., Chalk J., et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 51 1 (2002) 28-37
52. Butcher K.S., Parsons M., MacGregor L., et al. Refining the perfusion-diffusion mismatch hypothesis. Stroke 36 6 (2005) 1153-1159
53. Sandercock P., Wardlaw J., Dennis M., et al. EPITHET-where next?. Lancet Neurol 7 7 (2008) 570-571 [author reply 571-3]
54. Alexandrov A.W. Methodologic challenges in the design and conduct of hyperacute stroke research. AACN Adv Crit Care 19 2 (2008) 186-201
55. Higashida R.T., Furlan A.J., Roberts H., et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis or acute ischemic stroke. Stroke 34 8 (2003) e109-e137
56. Harris A.D., Kosior J.C., Ryder R.C., et al. MRI of ischemic stroke in canines: applications for monitoring intraarterial thrombolysis. J Magn Reson Imaging 26 6 (2007) 1421-1428
57. Messe S.R., Kasner S.E., Chalela J.A., et al. CT-NIHSS mismatch does not correlate with MRI diffusion-perfusion mismatch. Stroke 38 7 (2007) 2079-2084
58. Menezes N.M., Ay H., Wang Zhu M., et al. The real estate factor: quantifying the impact of infarct location on stroke severity. Stroke 38 1 (2007) 194-197
59. Simon J.E., Bristow M.S., Lu H., et al. A novel method to derive separate gray and white matter cerebral blood flow measures from MR imaging of acute ischemic stroke patients. J Cereb Blood Flow Metab 25 9 (2005) 1236-1243
60. Fiebach J.B., Schellinger P.D., Jansen O., et al. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 33 9 (2002) 2206-2210
61. Davis D.P., Robertson T., and Imbesi S.G. Diffusion-weighted magnetic resonance imaging versus computed tomography in the diagnosis of acute ischemic stroke. J Emerg Med 31 3 (2006) 269-277
62. Coutts S.B., Hill M.D., Simon J.E., et al. Silent ischemia in minor stroke and TIA patients identified on MR imaging. Neurology 65 4 (2005) 513-517
63. Ay H., Oliveira-Filho J., Buonanno F.S., et al. 'Footprints' of transient ischemic attacks: a diffusion-weighted MRI study. Cerebrovasc Dis 14 3-4 (2002) 177-186
64. Crisostomo R.A., Garcia M.M., and Tong D.C. Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: correlation with clinical characteristics. Stroke 34 4 (2003) 932-937
65. Inatomi Y., Kimura K., Yonehara T., et al. DWI abnormalities and clinical characteristics in TIA patients. Neurology 62 3 (2004) 376-380
66. Kidwell C.S., Alger J.R., Di Salle F., et al. Diffusion MRI in patients with transient ischemic attacks. Stroke 30 6 (1999) 1174-1180
67. Rovira A., Rovira-Gols A., Pedraza S., et al. Diffusion-weighted MR imaging in the acute phase of transient ischemic attacks. AJNR Am J Neuroradiol 23 1 (2002) 77-83
68. Coutts S.B., Simon J.E., Eliasziw M., et al. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol 57 6 (2005) 848-854
69. Prins N.D., van Dijk E.J., den Heijer T., et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol 61 10 (2004) 1531-1534
70. Vermeer S.E., Hollander M., van Dijk E.J., et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 34 5 (2003) 1126-1129
71. Vermeer S.E., Longstreth Jr. W.T., and Koudstaal P.J. Silent brain infarcts: a systematic review. Lancet Neurol 6 7 (2007) 611-619
72. Vermeer S.E., Prins N.D., den Heijer T., et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348 13 (2003) 1215-1222
73. Boulanger J.M., Coutts S.B., Eliasziw M., et al. Diffusion-weighted imaging-negative patients with transient ischemic attack are at risk of recurrent transient events. Stroke 38 8 (2007) 2367-2369
74. Sylaja P.N., Coutts S.B., Subramaniam S., et al. Acute ischemic lesions of varying ages predict risk of ischemic events in stroke/TIA patients. Neurology 68 6 (2007) 415-419
75. Ay H., Koroshetz W.J., Benner T., et al. Transient ischemic attack with infarction: a unique syndrome?. Ann Neurol 57 5 (2005) 679-686
76. Prabhakaran S., Chong J.Y., and Sacco R.L. Impact of abnormal diffusion-weighted imaging results on short-term outcome following transient ischemic attack. Arch Neurol 64 8 (2007) 1105-1109
77. Purroy F., Montaner J., Rovira A., et al. Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke 35 10 (2004) 2313-2319
78. Redgrave J.N., Coutts S.B., Schulz U.G., et al. Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. Stroke 38 5 (2007) 1482-1488
79. Calanchini P.R., Swanson P.D., Gotshall R.A., et al. Cooperative study of hospital frequency and character of transient ischemic attacks. IV. The reliability of diagnosis. JAMA 238 19 (1977) 2029-2033
80. Johnston S.C., Sidney S., Bernstein A.L., et al. A comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIA. Neurology 60 2 (2003) 280-285
81. Rajajee V., Kidwell C., Starkman S., et al. Diagnosis of lacunar infarcts within 6 hours of onset by clinical and CT criteria versus MRI. J Neuroimaging 18 1 (2008) 66-72
82. Oppenheim C., Lamy C., Touze E., et al. Do transient ischemic attacks with diffusion-weighted imaging abnormalities correspond to brain infarctions?. AJNR Am J Neuroradiol 27 8 (2006) 1782-1787
83. Krol A.L., Coutts S.B., Simon J.E., et al. Perfusion MRI abnormalities in speech or motor transient ischemic attack patients. Stroke 36 11 (2005) 2487-2489
84. Flossmann E., Redgrave J.N., Briley D., et al. Reliability of clinical diagnosis of the symptomatic vascular territory in patients with recent transient ischemic attack or minor stroke. Stroke 39 9 (2008) 2457-2460
85. Coutts S.B., Hill M.D., Campos C.R., et al. Recurrent events in transient ischemic attack and minor stroke: what events are happening and to which patients?. Stroke 39 9 (2008) 2461-2466
86. Lee L.J., Kidwell C.S., Alger J., et al. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 31 5 (2000) 1081-1089
87. Wessels T., Wessels C., Ellsiepen A., et al. Contribution of diffusion-weighted imaging in determination of stroke etiology. AJNR Am J Neuroradiol 27 1 (2006) 35-39
88. Restrepo L., Jacobs M.A., Barker P.B., et al. Etiology of perfusion-diffusion magnetic resonance imaging mismatch patterns. J Neuroimaging 15 3 (2005) 254-260